[1]
Azzman, N., Gill, M.S.A., Hassan, S.S. and Ahemad, N. 2023. Exploring the potential of Designed Multiple Ligands (DML) strategy with quinolones as anticancer. Current Trends in Biotechnology and Pharmacy. 17, 4A (Supplement) (Dec. 2023), 8–14. DOI:https://doi.org/10.5530/ctbp.2023.4s.84.